Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression

Biological Psychiatry

Volumn 67, Issue 2, 2010, Pages 110-116

  Bewernick, Bettina H ^a   Hurlemann, René ^a   Matusch, Andreas ^a   Kayser, Sarah ^a   Grubert, Christiane ^a   Hadrysiewicz, Barbara ^a   Axmacher, Nikolai ^a   Lemke, Matthias ^e   Cooper Mahkorn, Deirdre ^a   Cohen, Michael X ^d   Brockmann, Holger ^a   Lenartz, Doris ^c   Sturm, Volker ^c   Schlaepfer, Thomas E ^a,b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Alsterdorf Hospital   (Germany)

Author keywords

Deep brain stimulation; functional neuroimaging; major depression; neuromodulation; nucleus accumbens; treatment resistance

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUSPIRONE; FLUORODEOXYGLUCOSE F 18; LIOTHYRONINE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGITATION; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DYSPHAGIA; ELECTROCONVULSIVE THERAPY; ELECTRODE; ERYTHEMA; EYE SWELLING; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MALE; MUSCLE CRAMP; NUCLEUS ACCUMBENS; PAIN; PARESTHESIA; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOTHERAPY; SWEATING; THALAMUS; TREATMENT DURATION;

ADULT; AGED; AMYGDALA; BRAIN MAPPING; DEEP BRAIN STIMULATION; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NUCLEUS ACCUMBENS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 71649103156     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.09.013     Document Type: Article

References (38)

1. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005) 593-602
2. Fava M., and Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19 (1996) 179-200
3. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry 163 (2006) 1905-1917
4. Holtzheimer P.E., and Nemeroff C.B. Novel targets for antidepressant therapies. Curr Psychiatry Rep 10 (2008) 465-473
5. Schlaepfer T., and Lieb K. Deep brain stimulation for treatment refractory depression. Lancet 366 (2005) 1420-1422
6. Krishnan V., and Nestler E.J. The molecular neurobiology of depression. Nature 455 (2008) 894-902
7. Berton O., and Nestler E.J. New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci 7 (2006) 137-151
8. Lozano A.M., Mayberg H.S., Giacobbe P., Hamani C., Craddock R.C., and Kennedy S.H. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64 (2008) 461-467
9. Malone Jr. D.A., Dougherty D.D., Rezai A.R., Carpenter L.L., Friehs G.M., Eskandar E.N., et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 65 (2009) 267-275
10. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropschopharmacology 33 (2008) 368-377
11. Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci 10 (2008) 291-299
12. Epstein J., Pan H., Kocsis J.H., Yang Y., Butler T., Chusid J., et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 163 (2006) 1784-1790
13. Tremblay L.K., Naranjo C.A., Graham S.J., Herrmann N., Mayberg H.S., Hevenor S., et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62 (2005) 1228-1236
14. Synofzyk M., and Schlaepfer T.E. Stimulating personality: Ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. J Biotechnol 3 (2008) 1511-1520
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
16. Rosenthal S.H., and Klerman G.L. Endogenous features of depression in women. Can Psychiatr Assoc J 11 suppl (1966) 11-16
17. Endicott J., Cohen J., Nee J., Fleiss J., and Sarantakos S. Hamilton Depression Rating Scale. Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 38 (1981) 98-103
18. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
19. Hamilton M. HAMA Hamilton Anxiety Scale. In: Guy W. (Ed). ECDEU Assessment Manual for Psychopharmacology (1976), National Institute of Mental Health, Rockville, MD 193-198
20. Beck A. Beck Depression Inventory: Manual (1987), Psychological Corporation, San Antonio, TX
21. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., and Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 26 (1996) 477-486
22. Franke G. SCL-90-R. Die Symptom-CHeckliste von Derogatis (Deutsche Version) (1995), Beltz-Verlag, Weinheim, Germany
23. Hautzinger M. Kognitive Verhaltenstherapie bei Depressionen (2000), Beltz, München, Weinheim, Germany
24. Lewinsohn P.M., and Graf M. Pleasant activities and depression. J Consult Clin Psychol 41 (1973) 261-268
25. Deuschl G., Schade-Brittinger C., Krack P., Volkmann J., Schafer H., Botzel K., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355 (2006) 896-908
26. Mayberg H. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65 (2003) 193-207
27. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 156 (1999) 675-682
28. Ressler K.J., and Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nat Neurosci 10 (2007) 1116-1124
29. Mayberg H., Lozano A., Voon V., McNeely H., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
30. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131 (2007) 391-404
31. Berton O., McClung C.A., DiLeone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006) 864-868
32. Cohen M.X., Axmacher N., Lenartz D., Elger C.E., Sturm V., and Schlaepfer T.E. Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology 34 (2009) 1649-1658
33. Gutman D.A., Holtzheimer P.E., Behrens T.E., Johansen-Berg H., and Mayberg H.S. A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry 65 (2009) 276-282
34. Cohen M.X., Axmacher N., Lenartz D., Elger C.E., Sturm V., and Schlaepfer T.E. Good vibrations: Cross-frequency coupling in the human nucleus accumbens during reward processing. J Cogn Neurosci 21 (2009) 875-879
35. Nitschke J.B., Sarinopoulos I., Oathes D.J., Johnstone T., Whalen P.J., Davidson R.J., and Kalin N.H. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 166 (2009) 302-310
36. Schatzberg A.F., and Kraemer H.C. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry 47 (2000) 736-744
37. Rush A.J., Sackeim H.A., Marangell L.B., George M.S., Brannan S.K., Davis S.M., et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study. Biol Psychiatry 58 (2005) 355-363
38. Sackeim H.A. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 suppl 16 (2001) 10-17